HomeNewsBino pathiparampil of iifl

Bino Pathiparampil Of Iifl

Jump to

Watch out for Q4 earnings before buying Sun Pharma: IIFL

Bino Pathiparampil of IIFL said he would wait and watch for the quarter numbers before jumping freshly into Sun Pharma.
Re-rating story will continue in Wockhardt: Pathiparampil

Bino Pathiparampil of IIFL believes the re-rating story will continue in Wockhardt. He expects some good returns going forward.
Do not see secular upside in Ranbaxy: Pathiparampil

Bino Pathiparampil of IIFL says he does not see a secular upside in Ranbaxy Labs even at these levels. According to him, the stock continues to be expensive even after the underperformance.
Pharma sector will outperform broader markets: IIFL

Bino Pathiparampil of IIFL is overweight on pharma space. According to him, the sector will outperform the broader markets.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347